News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
726,387 Results
Type
Article (42106)
Company Profile (300)
Press Release (683979)
Multimedia
Podcasts (85)
Webinars (18)
Section
Business (207051)
Career Advice (2023)
Deals (35887)
Drug Delivery (107)
Drug Development (82757)
Employer Resources (173)
FDA (16551)
Job Trends (15091)
News (350514)
Policy (33015)
Tag
Academia (2604)
Accelerated approval (22)
Adcomms (28)
Allergies (123)
Alliances (50435)
ALS (153)
Alzheimer's disease (1622)
Antibody-drug conjugate (ADC) (276)
Approvals (16701)
Artificial intelligence (471)
Autoimmune disease (110)
Automation (33)
Bankruptcy (362)
Best Places to Work (11788)
BIOSECURE Act (20)
Biosimilars (170)
Biotechnology (200)
Bladder cancer (145)
Brain cancer (55)
Breast cancer (549)
Cancer (4367)
Cardiovascular disease (353)
Career advice (1706)
Career pathing (34)
CAR-T (255)
CDC (46)
Cell therapy (669)
Cervical cancer (34)
Clinical research (69934)
Collaboration (1467)
Company closure (4)
Compensation (1017)
Complete response letters (48)
COVID-19 (2711)
CRISPR (84)
C-suite (691)
Cystic fibrosis (136)
Data (5432)
Decentralized trials (2)
Denatured (25)
Depression (108)
Diabetes (451)
Diagnostics (6680)
Digital health (39)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (221)
Drug pricing (168)
Drug shortages (28)
Duchenne muscular dystrophy (204)
Earnings (90495)
Editorial (53)
Employer branding (21)
Employer resources (151)
Events (118669)
Executive appointments (984)
FDA (19248)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1328)
Gene editing (183)
Generative AI (40)
Gene therapy (525)
GLP-1 (923)
Government (4675)
Grass and pollen (7)
Guidances (377)
Healthcare (19129)
HIV (48)
Huntington's disease (38)
IgA nephropathy (74)
Immunology and inflammation (230)
Immuno-oncology (28)
Indications (68)
Infectious disease (2953)
Inflammatory bowel disease (180)
Inflation Reduction Act (13)
Influenza (101)
Intellectual property (207)
Interviews (315)
IPO (16790)
IRA (49)
Job creations (3671)
Job search strategy (1432)
Kidney cancer (16)
Labor market (79)
Layoffs (561)
Leadership (29)
Legal (7985)
Liver cancer (92)
Longevity (12)
Lung cancer (620)
Lymphoma (318)
Machine learning (34)
Management (59)
Manufacturing (650)
MASH (154)
Medical device (13749)
Medtech (13784)
Mergers & acquisitions (20050)
Metabolic disorders (1124)
Multiple sclerosis (143)
NASH (17)
Neurodegenerative disease (270)
Neuropsychiatric disorders (64)
Neuroscience (2684)
NextGen: Class of 2025 (6591)
Non-profit (4541)
Now hiring (60)
Obesity (515)
Opinion (252)
Ovarian cancer (148)
Pain (165)
Pancreatic cancer (193)
Parkinson's disease (248)
Partnered (30)
Patents (437)
Patient recruitment (372)
Peanut (53)
People (59300)
Pharmaceutical (68)
Pharmacy benefit managers (26)
Phase I (21846)
Phase II (30751)
Phase III (22963)
Pipeline (3541)
Policy (268)
Postmarket research (2599)
Preclinical (9295)
Press Release (64)
Prostate cancer (222)
Psychedelics (44)
Radiopharmaceuticals (272)
Rare diseases (674)
Real estate (6009)
Recruiting (69)
Regulatory (24101)
Reports (51)
Research institute (2427)
Resumes & cover letters (351)
Rett syndrome (21)
RNA editing (14)
RSV (73)
Schizophrenia (135)
Series A (213)
Series B (166)
Service/supplier (11)
Sickle cell disease (84)
Special edition (21)
Spinal muscular atrophy (153)
Sponsored (38)
Startups (3675)
State (2)
Stomach cancer (18)
Supply chain (98)
Tariffs (81)
The Weekly (58)
Vaccines (953)
Venture capital (72)
Weight loss (338)
Women's health (68)
Worklife (17)
Date
Last 7 days (557)
Last 30 days (2471)
Last 365 days (31058)
2025 (29508)
2024 (35830)
2023 (40562)
2022 (51764)
2021 (56297)
2020 (54613)
2019 (47121)
2018 (35505)
2017 (32701)
2016 (32069)
2015 (38109)
2014 (31793)
2013 (26753)
2012 (28953)
2011 (29683)
2010 (27642)
Location
Africa (744)
Alabama (79)
Alaska (7)
Arizona (284)
Arkansas (13)
Asia (39726)
Australia (6497)
California (10329)
Canada (3048)
China (956)
Colorado (432)
Connecticut (453)
Delaware (298)
Europe (86986)
Florida (1522)
Georgia (326)
Hawaii (2)
Idaho (62)
Illinois (795)
India (56)
Indiana (482)
Iowa (21)
Japan (355)
Kansas (123)
Kentucky (37)
Louisiana (24)
Maine (70)
Maryland (1328)
Massachusetts (7566)
Michigan (296)
Minnesota (582)
Mississippi (5)
Missouri (120)
Montana (32)
Nebraska (26)
Nevada (110)
New Hampshire (73)
New Jersey (2825)
New Mexico (28)
New York (2769)
North Carolina (1355)
North Dakota (10)
Northern California (4900)
Ohio (302)
Oklahoma (21)
Oregon (38)
Pennsylvania (2124)
Puerto Rico (19)
Rhode Island (44)
South America (1112)
South Carolina (58)
South Dakota (1)
Southern California (4012)
Tennessee (163)
Texas (1585)
United States (37137)
Utah (305)
Vermont (1)
Virginia (241)
Washington D.C. (80)
Washington State (838)
West Virginia (4)
Wisconsin (102)
Wyoming (2)
726,387 Results for "f1 oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rakovina Therapeutics Inc. Announces Presentation of Second Abstract at the 2025 Society for Neuro-Oncology Annual Meeting
November 24, 2025
·
4 min read
Job Trends
9 Companies Hiring in Oncology
Looking for a job in oncology? Check out the
BioSpace
list of nine companies hiring life sciences professionals like you.
October 9, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Syncromune®, Inc. Presents Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at Society of Urological Oncology 26th Annual Meeting
December 4, 2025
·
7 min read
Press Releases
Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference
October 27, 2025
·
7 min read
Press Releases
Syncromune®, Inc. to Present Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at the Society of Urological Oncology 26th Annual Meeting
November 21, 2025
·
5 min read
Press Releases
Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001
August 18, 2025
·
3 min read
Press Releases
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
October 31, 2025
·
2 min read
Press Releases
Verastem Oncology to Present at the 8th Annual Evercore Healthcare Conference
November 26, 2025
·
1 min read
Press Releases
Syndax’s Revuforj® (revumenib) Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the Treatment of Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia
September 22, 2025
·
12 min read
Press Releases
Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update
August 13, 2025
·
8 min read
1 of 72,639
Next
